Report Detail
Global Cyclodextrins in Pharmaceutical Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032
- RnM4698121 |
- 21 May, 2026 |
- Global |
- 125 Pages |
- GIR |
- Medical Devices & Consumables
According to our (Global Info Research) latest study, the global Cyclodextrins in Pharmaceutical market size was valued at US$ million in 2025 and is forecast to a readjusted size of US$ million by 2032 with a CAGR of %during review period.
Cyclodextrins are cyclic oligomers of glucose that have a significant number of applications in the pharmaceutical industries. Water-soluble cyclodextrins can form inclusion complexes with small molecules and portions of large compounds that have limited aqueous solubility to provide improved bioavailability of drugs.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report is a detailed and comprehensive analysis for global Cyclodextrins in Pharmaceutical market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Cyclodextrins in Pharmaceutical market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
Global Cyclodextrins in Pharmaceutical market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
Global Cyclodextrins in Pharmaceutical market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
Global Cyclodextrins in Pharmaceutical market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2021-2026
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Cyclodextrins in Pharmaceutical
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Cyclodextrins in Pharmaceutical market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Ashland, Cambrex Corporation, Cayman Chemical, Cyclo Therapeutics, Ligand Pharmaceuticals Incorporated, Merck KGaA, Midas Pharma GmbH, Otto Chemie, TCI Chemicals, VIO CHEMICALS, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
Cyclodextrins in Pharmaceutical market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Solid
Liquid
Market segment by Application
Drug Safety
Medical Laboratory
Others
Major players covered
Ashland
Cambrex Corporation
Cayman Chemical
Cyclo Therapeutics
Ligand Pharmaceuticals Incorporated
Merck KGaA
Midas Pharma GmbH
Otto Chemie
TCI Chemicals
VIO CHEMICALS
Wacker Chemie AG
Wellona Pharma
Market segment by region, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Cyclodextrins in Pharmaceutical product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Cyclodextrins in Pharmaceutical, with price, sales quantity, revenue, and global market share of Cyclodextrins in Pharmaceutical from 2021 to 2026.
Chapter 3, the Cyclodextrins in Pharmaceutical competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Cyclodextrins in Pharmaceutical breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2021 to 2032.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2021 to 2032.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2021 to 2026.and Cyclodextrins in Pharmaceutical market forecast, by regions, by Type, and by Application, with sales and revenue, from 2027 to 2032.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Cyclodextrins in Pharmaceutical.
Chapter 14 and 15, to describe Cyclodextrins in Pharmaceutical sales channel, distributors, customers, research findings and conclusion.
1 Market Overview
- 1.1 Product Overview and Scope
- 1.2 Market Estimation Caveats and Base Year
- 1.3 Market Analysis by Type
- 1.3.1 Overview: Global Cyclodextrins in Pharmaceutical Consumption Value by Type: 2021 Versus 2025 Versus 2032
- 1.3.2 Solid
- 1.3.3 Liquid
- 1.4 Market Analysis by Application
- 1.4.1 Overview: Global Cyclodextrins in Pharmaceutical Consumption Value by Application: 2021 Versus 2025 Versus 2032
- 1.4.2 Drug Safety
- 1.4.3 Medical Laboratory
- 1.4.4 Others
- 1.5 Global Cyclodextrins in Pharmaceutical Market Size & Forecast
- 1.5.1 Global Cyclodextrins in Pharmaceutical Consumption Value (2021 & 2025 & 2032)
- 1.5.2 Global Cyclodextrins in Pharmaceutical Sales Quantity (2021-2032)
- 1.5.3 Global Cyclodextrins in Pharmaceutical Average Price (2021-2032)
2 Manufacturers Profiles
- 2.1 Ashland
- 2.1.1 Ashland Details
- 2.1.2 Ashland Major Business
- 2.1.3 Ashland Cyclodextrins in Pharmaceutical Product and Services
- 2.1.4 Ashland Cyclodextrins in Pharmaceutical Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.1.5 Ashland Recent Developments/Updates
- 2.2 Cambrex Corporation
- 2.2.1 Cambrex Corporation Details
- 2.2.2 Cambrex Corporation Major Business
- 2.2.3 Cambrex Corporation Cyclodextrins in Pharmaceutical Product and Services
- 2.2.4 Cambrex Corporation Cyclodextrins in Pharmaceutical Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.2.5 Cambrex Corporation Recent Developments/Updates
- 2.3 Cayman Chemical
- 2.3.1 Cayman Chemical Details
- 2.3.2 Cayman Chemical Major Business
- 2.3.3 Cayman Chemical Cyclodextrins in Pharmaceutical Product and Services
- 2.3.4 Cayman Chemical Cyclodextrins in Pharmaceutical Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.3.5 Cayman Chemical Recent Developments/Updates
- 2.4 Cyclo Therapeutics
- 2.4.1 Cyclo Therapeutics Details
- 2.4.2 Cyclo Therapeutics Major Business
- 2.4.3 Cyclo Therapeutics Cyclodextrins in Pharmaceutical Product and Services
- 2.4.4 Cyclo Therapeutics Cyclodextrins in Pharmaceutical Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.4.5 Cyclo Therapeutics Recent Developments/Updates
- 2.5 Ligand Pharmaceuticals Incorporated
- 2.5.1 Ligand Pharmaceuticals Incorporated Details
- 2.5.2 Ligand Pharmaceuticals Incorporated Major Business
- 2.5.3 Ligand Pharmaceuticals Incorporated Cyclodextrins in Pharmaceutical Product and Services
- 2.5.4 Ligand Pharmaceuticals Incorporated Cyclodextrins in Pharmaceutical Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.5.5 Ligand Pharmaceuticals Incorporated Recent Developments/Updates
- 2.6 Merck KGaA
- 2.6.1 Merck KGaA Details
- 2.6.2 Merck KGaA Major Business
- 2.6.3 Merck KGaA Cyclodextrins in Pharmaceutical Product and Services
- 2.6.4 Merck KGaA Cyclodextrins in Pharmaceutical Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.6.5 Merck KGaA Recent Developments/Updates
- 2.7 Midas Pharma GmbH
- 2.7.1 Midas Pharma GmbH Details
- 2.7.2 Midas Pharma GmbH Major Business
- 2.7.3 Midas Pharma GmbH Cyclodextrins in Pharmaceutical Product and Services
- 2.7.4 Midas Pharma GmbH Cyclodextrins in Pharmaceutical Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.7.5 Midas Pharma GmbH Recent Developments/Updates
- 2.8 Otto Chemie
- 2.8.1 Otto Chemie Details
- 2.8.2 Otto Chemie Major Business
- 2.8.3 Otto Chemie Cyclodextrins in Pharmaceutical Product and Services
- 2.8.4 Otto Chemie Cyclodextrins in Pharmaceutical Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.8.5 Otto Chemie Recent Developments/Updates
- 2.9 TCI Chemicals
- 2.9.1 TCI Chemicals Details
- 2.9.2 TCI Chemicals Major Business
- 2.9.3 TCI Chemicals Cyclodextrins in Pharmaceutical Product and Services
- 2.9.4 TCI Chemicals Cyclodextrins in Pharmaceutical Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.9.5 TCI Chemicals Recent Developments/Updates
- 2.10 VIO CHEMICALS
- 2.10.1 VIO CHEMICALS Details
- 2.10.2 VIO CHEMICALS Major Business
- 2.10.3 VIO CHEMICALS Cyclodextrins in Pharmaceutical Product and Services
- 2.10.4 VIO CHEMICALS Cyclodextrins in Pharmaceutical Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.10.5 VIO CHEMICALS Recent Developments/Updates
- 2.11 Wacker Chemie AG
- 2.11.1 Wacker Chemie AG Details
- 2.11.2 Wacker Chemie AG Major Business
- 2.11.3 Wacker Chemie AG Cyclodextrins in Pharmaceutical Product and Services
- 2.11.4 Wacker Chemie AG Cyclodextrins in Pharmaceutical Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.11.5 Wacker Chemie AG Recent Developments/Updates
- 2.12 Wellona Pharma
- 2.12.1 Wellona Pharma Details
- 2.12.2 Wellona Pharma Major Business
- 2.12.3 Wellona Pharma Cyclodextrins in Pharmaceutical Product and Services
- 2.12.4 Wellona Pharma Cyclodextrins in Pharmaceutical Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.12.5 Wellona Pharma Recent Developments/Updates
3 Competitive Environment: Cyclodextrins in Pharmaceutical by Manufacturer
- 3.1 Global Cyclodextrins in Pharmaceutical Sales Quantity by Manufacturer (2021-2026)
- 3.2 Global Cyclodextrins in Pharmaceutical Revenue by Manufacturer (2021-2026)
- 3.3 Global Cyclodextrins in Pharmaceutical Average Price by Manufacturer (2021-2026)
- 3.4 Market Share Analysis (2025)
- 3.4.1 Producer Shipments of Cyclodextrins in Pharmaceutical by Manufacturer Revenue ($MM) and Market Share (%): 2025
- 3.4.2 Top 3 Cyclodextrins in Pharmaceutical Manufacturer Market Share in 2025
- 3.4.3 Top 6 Cyclodextrins in Pharmaceutical Manufacturer Market Share in 2025
- 3.5 Cyclodextrins in Pharmaceutical Market: Overall Company Footprint Analysis
- 3.5.1 Cyclodextrins in Pharmaceutical Market: Region Footprint
- 3.5.2 Cyclodextrins in Pharmaceutical Market: Company Product Type Footprint
- 3.5.3 Cyclodextrins in Pharmaceutical Market: Company Product Application Footprint
- 3.6 New Market Entrants and Barriers to Market Entry
- 3.7 Mergers, Acquisition, Agreements, and Collaborations
4 Consumption Analysis by Region
- 4.1 Global Cyclodextrins in Pharmaceutical Market Size by Region
- 4.1.1 Global Cyclodextrins in Pharmaceutical Sales Quantity by Region (2021-2032)
- 4.1.2 Global Cyclodextrins in Pharmaceutical Consumption Value by Region (2021-2032)
- 4.1.3 Global Cyclodextrins in Pharmaceutical Average Price by Region (2021-2032)
- 4.2 North America Cyclodextrins in Pharmaceutical Consumption Value (2021-2032)
- 4.3 Europe Cyclodextrins in Pharmaceutical Consumption Value (2021-2032)
- 4.4 Asia-Pacific Cyclodextrins in Pharmaceutical Consumption Value (2021-2032)
- 4.5 South America Cyclodextrins in Pharmaceutical Consumption Value (2021-2032)
- 4.6 Middle East & Africa Cyclodextrins in Pharmaceutical Consumption Value (2021-2032)
5 Market Segment by Type
- 5.1 Global Cyclodextrins in Pharmaceutical Sales Quantity by Type (2021-2032)
- 5.2 Global Cyclodextrins in Pharmaceutical Consumption Value by Type (2021-2032)
- 5.3 Global Cyclodextrins in Pharmaceutical Average Price by Type (2021-2032)
6 Market Segment by Application
- 6.1 Global Cyclodextrins in Pharmaceutical Sales Quantity by Application (2021-2032)
- 6.2 Global Cyclodextrins in Pharmaceutical Consumption Value by Application (2021-2032)
- 6.3 Global Cyclodextrins in Pharmaceutical Average Price by Application (2021-2032)
7 North America
- 7.1 North America Cyclodextrins in Pharmaceutical Sales Quantity by Type (2021-2032)
- 7.2 North America Cyclodextrins in Pharmaceutical Sales Quantity by Application (2021-2032)
- 7.3 North America Cyclodextrins in Pharmaceutical Market Size by Country
- 7.3.1 North America Cyclodextrins in Pharmaceutical Sales Quantity by Country (2021-2032)
- 7.3.2 North America Cyclodextrins in Pharmaceutical Consumption Value by Country (2021-2032)
- 7.3.3 United States Market Size and Forecast (2021-2032)
- 7.3.4 Canada Market Size and Forecast (2021-2032)
- 7.3.5 Mexico Market Size and Forecast (2021-2032)
8 Europe
- 8.1 Europe Cyclodextrins in Pharmaceutical Sales Quantity by Type (2021-2032)
- 8.2 Europe Cyclodextrins in Pharmaceutical Sales Quantity by Application (2021-2032)
- 8.3 Europe Cyclodextrins in Pharmaceutical Market Size by Country
- 8.3.1 Europe Cyclodextrins in Pharmaceutical Sales Quantity by Country (2021-2032)
- 8.3.2 Europe Cyclodextrins in Pharmaceutical Consumption Value by Country (2021-2032)
- 8.3.3 Germany Market Size and Forecast (2021-2032)
- 8.3.4 France Market Size and Forecast (2021-2032)
- 8.3.5 United Kingdom Market Size and Forecast (2021-2032)
- 8.3.6 Russia Market Size and Forecast (2021-2032)
- 8.3.7 Italy Market Size and Forecast (2021-2032)
9 Asia-Pacific
- 9.1 Asia-Pacific Cyclodextrins in Pharmaceutical Sales Quantity by Type (2021-2032)
- 9.2 Asia-Pacific Cyclodextrins in Pharmaceutical Sales Quantity by Application (2021-2032)
- 9.3 Asia-Pacific Cyclodextrins in Pharmaceutical Market Size by Region
- 9.3.1 Asia-Pacific Cyclodextrins in Pharmaceutical Sales Quantity by Region (2021-2032)
- 9.3.2 Asia-Pacific Cyclodextrins in Pharmaceutical Consumption Value by Region (2021-2032)
- 9.3.3 China Market Size and Forecast (2021-2032)
- 9.3.4 Japan Market Size and Forecast (2021-2032)
- 9.3.5 South Korea Market Size and Forecast (2021-2032)
- 9.3.6 India Market Size and Forecast (2021-2032)
- 9.3.7 Southeast Asia Market Size and Forecast (2021-2032)
- 9.3.8 Australia Market Size and Forecast (2021-2032)
10 South America
- 10.1 South America Cyclodextrins in Pharmaceutical Sales Quantity by Type (2021-2032)
- 10.2 South America Cyclodextrins in Pharmaceutical Sales Quantity by Application (2021-2032)
- 10.3 South America Cyclodextrins in Pharmaceutical Market Size by Country
- 10.3.1 South America Cyclodextrins in Pharmaceutical Sales Quantity by Country (2021-2032)
- 10.3.2 South America Cyclodextrins in Pharmaceutical Consumption Value by Country (2021-2032)
- 10.3.3 Brazil Market Size and Forecast (2021-2032)
- 10.3.4 Argentina Market Size and Forecast (2021-2032)
11 Middle East & Africa
- 11.1 Middle East & Africa Cyclodextrins in Pharmaceutical Sales Quantity by Type (2021-2032)
- 11.2 Middle East & Africa Cyclodextrins in Pharmaceutical Sales Quantity by Application (2021-2032)
- 11.3 Middle East & Africa Cyclodextrins in Pharmaceutical Market Size by Country
- 11.3.1 Middle East & Africa Cyclodextrins in Pharmaceutical Sales Quantity by Country (2021-2032)
- 11.3.2 Middle East & Africa Cyclodextrins in Pharmaceutical Consumption Value by Country (2021-2032)
- 11.3.3 Turkey Market Size and Forecast (2021-2032)
- 11.3.4 Egypt Market Size and Forecast (2021-2032)
- 11.3.5 Saudi Arabia Market Size and Forecast (2021-2032)
- 11.3.6 South Africa Market Size and Forecast (2021-2032)
12 Market Dynamics
- 12.1 Cyclodextrins in Pharmaceutical Market Drivers
- 12.2 Cyclodextrins in Pharmaceutical Market Restraints
- 12.3 Cyclodextrins in Pharmaceutical Trends Analysis
- 12.4 Porters Five Forces Analysis
- 12.4.1 Threat of New Entrants
- 12.4.2 Bargaining Power of Suppliers
- 12.4.3 Bargaining Power of Buyers
- 12.4.4 Threat of Substitutes
- 12.4.5 Competitive Rivalry
13 Raw Material and Industry Chain
- 13.1 Raw Material of Cyclodextrins in Pharmaceutical and Key Manufacturers
- 13.2 Manufacturing Costs Percentage of Cyclodextrins in Pharmaceutical
- 13.3 Cyclodextrins in Pharmaceutical Production Process
- 13.4 Industry Value Chain Analysis
14 Shipments by Distribution Channel
- 14.1 Sales Channel
- 14.1.1 Direct to End-User
- 14.1.2 Distributors
- 14.2 Cyclodextrins in Pharmaceutical Typical Distributors
- 14.3 Cyclodextrins in Pharmaceutical Typical Customers
15 Research Findings and Conclusion
16 Appendix
- 16.1 Methodology
- 16.2 Research Process and Data Source
Summary:
Get latest Market Research Reports on Cyclodextrins in Pharmaceutical. Industry analysis & Market Report on Cyclodextrins in Pharmaceutical is a syndicated market report, published as Global Cyclodextrins in Pharmaceutical Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032. It is complete Research Study and Industry Analysis of Cyclodextrins in Pharmaceutical market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
